Diabetes

mAb glucagon receptor blocker suitable for further development

(HealthDay)—The glucagon receptor blocker REGN1193, a fully human monoclonal antibody, seems safe and tolerable enough for further development, according to a study published online July 28 in Diabetes, Obesity and Metabolism.

Diabetes

PCSK9 increased in females, youth with type 1 diabetes

(HealthDay)—Proprotein convertase subtilisin/kexin type 9 (PCSK9) is increased in young females and youth with type 1 diabetes (T1D), according to research published online June 6 in Diabetes Care.

Health

Microgreen study shows health benefits

"Microgreens" are tender young plants grown from the seed of certain herb, vegetable, and grain crops that can be clipped at the stem and eaten fresh within 2 weeks of germinating.

Cardiology

Evacetrapib appears futile in high-risk vascular disease

(HealthDay)—For patients with high-risk vascular disease, evacetrapib does not affect the primary efficacy end point of first occurrence of any component of a composite of death from cardiovascular causes, myocardial infarction, ...

Diseases, Conditions, Syndromes

Baricitinib associated with significant improvement in RA

(HealthDay)—For patients with rheumatoid arthritis who have had an inadequate response to methotrexate, baricitinib is associated with significant clinical improvements, compared to either placebo or adalimumab, according ...

Diabetes

Similar metabolic response to animal, plant protein diets

(HealthDay)—For patients with type 2 diabetes mellitus (T2DM), isocaloric diets high in animal protein (AP) or plant protein (PP) are associated with similar improvements in metabolism and cardiovascular risk factors, according ...

page 16 from 26